CD30-postive lymphoproliferative disorder with lesions at depot injection sites, associated with mycosis fungoides and prostatic carcinoma.

CD30-postive lymphoproliferative disorder with lesions at depot injection sites, associated with mycosis fungoides and prostatic carcinoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

CD30-postive lymphoproliferative disorder with lesions at depot injection sites, associated with mycosis fungoides and prostatic carcinoma. Abstract Text:

N H Cox,V Madan,A W Popple,B Angus,N H Cox,V Madan,A W Popple,B Angus,

CD30-postive lymphoproliferative disorder with lesions at depot injection sites, associated with mycosis fungoides and prostatic carcinoma. Publishing Authors By Initials

NH Cox,V Madan,AW Popple,B Angus,NH Cox,V Madan,AW Popple,B Angus,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

CD30-postive lymphoproliferative disorder with lesions at depot injection sites, associated with mycosis fungoides and prostatic carcinoma. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Clinical and experimental dermatology

VOLUME: 33

Page Numbers: 101-2

Journal Abbreviation: Clin. Exp. Dermatol.

ISSN: 0307-6938

DAY: 7

MONTH: Jan

YEAR: 2008

CD30-postive lymphoproliferative disorder with lesions at depot injection sites, associated with mycosis fungoides and prostatic carcinoma. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7606847

CD30-postive lymphoproliferative disorder with lesions at depot injection sites, associated with mycosis fungoides and prostatic carcinoma. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: CD30-postive lymphoproliferative disorder with lesions at depot injection sites, associated with mycosis fungoides and prostatic carcinoma. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for CD30-postive lymphoproliferative disorder with lesions at depot injection sites, associated with mycosis fungoides and prostatic carcinoma.

AFFILIATION: Department of Dermatology, Cumberland Infirmary, Carlisle, CA2 7HY, UK.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Clin Exp Dermatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

CD30-postive lymphoproliferative disorder with lesions at depot injection sites, associated with mycosis fungoides and prostatic carcinoma Related Publications

• A health centre survey of childhood injury in Edmonton.
• A spread spectrum technique for the study of outdoor noise propagation.
• CD30-postive lymphoproliferative disorder with lesions at depot injection sites, associated with mycosis fungoides and prostatic carcinoma.
• Dysfunctional immune-privilege in morbid obesity: implications and effect of gastric bypass surgery.
• Effect of surgically-induced weight loss on leukocyte indicators of chronic inflammation in morbid obesity.
• Effect of sustained viral response on hepatic venous pressure gradient in hepatitis C-related cirrhosis.
• Effects of sonication and advanced chemical oxidants on the unicellular green alga Dunaliella tertiolecta and cysts, larvae and adults of the brine shrimp Artemia salina: A prospective treatment to eradicate invasive organisms from ballast water.
• Follow-up of nutritional surveys.
• Health policy and future planning for survivors of critical illness.
• Implementation of early goal-directed therapy for severe sepsis and septic shock: A decision analysis.
• Inoprotection: the perioperative role of levosimendan.
• Long-term Outcomes from Sepsis.
• PAC-Man: game over for the pulmonary artery catheter?
• Perceptions of safety culture vary across the intensive care units of a single institution.
• Persistent depression of contractility and vasodilation with propofol but not with sevoflurane or desflurane in rabbits.
• Potential value of regionalized intensive care for mechanically ventilated medical patients.
• Prefrontal lobotomy as a method of therapy in a special school.
• Psychiatry in the field of mental deficiency.
• Racial variation in end-of-life intensive care use: a race or hospital effect?
• Racial variation in the incidence, care, and outcomes of severe sepsis: analysis of population, patient, and hospital characteristics.
• Relationship between staff perceptions of hospital norms and hospital-level end-of-life treatment intensity.
• Some physical aspects of housing.
• Technological innovations in health care: the need for technology assessment.
• Testing protocols in the intensive care unit: complex trials of complex interventions for complex patients.
• The effect of obesity on neutrophil Fc receptors and adhesion molecules (CD16, CD11b, CD62L).
• Time to review the selection criteria for transplantation in paracetamol-induced fulminant hepatic failure?
• Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study.
• Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis.
• Use of dynamic microsimulation to predict disease progression in patients with pneumonia-related sepsis.
• Venous reactivity in canine renovascular hypertension.